Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/1646
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Pandi Perumal, Seithikurippu R. | es |
dc.contributor.author | Spence, David Warren | es |
dc.contributor.author | Verster, Joris C. | es |
dc.contributor.author | Srinivasan, Venkataramanujan | es |
dc.contributor.author | Brown, Gregory M. | es |
dc.contributor.author | Cardinali, Daniel Pedro | es |
dc.contributor.author | Hardeland, Rüdiger | es |
dc.date.accessioned | 2019-05-02T14:01:15Z | - |
dc.date.available | 2019-05-02T14:01:15Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Pandi-Perumal, S. R., et al. Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications. Journal of Central Nervous System Disease. 2011, 3. doi:10.4137/JCNSD.S1611. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1646 | es |
dc.identifier.issn | 1179-5735 (online) | - |
dc.identifier.issn | 1179-5735 (impreso) | - |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/1646 | - |
dc.description.abstract | Abstract: Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT1 and MT2 melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ramelteon is both a chronobiotic and a hypnotic that has been shown to promote sleep initiation and maintenance in various preclinical and in clinical trials. The efficacy and safety of ramelteon in patients with chronic insomnia was initially confirmed in short-term placebo-controlled trials. These showed little evidence of next-day residual effects, withdrawal symptoms or rebound insomnia. Other studies indicated that ramelteon lacked abuse potential and had a minimal risk of producing dependence or adverse effects on cognitive or psychomotor performance. A 6-month placebo-controlled international study and a 1-year open-label study in the USA demonstrated that ramelteon was effective and well tolerated. Other potential off-label uses of ramelteon include circadian rhythm sleep disorders such as shift-work and jet lag. At the present time the drug should be cautiously prescribed for short-term treatment only. | es |
dc.format | application/pdf | es |
dc.language | eng | es |
dc.language.iso | eng | es |
dc.publisher | Libertas Academica | es |
dc.rights | Acceso Abierto | es |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | es |
dc.source | Journal of Central Nervous System Disease. 2011, 3 | es |
dc.subject | RITMO CIRCADIANO | es |
dc.subject | MELATONINA | es |
dc.subject | RAMELTEON | es |
dc.subject | SUEÑO | es |
dc.subject | INSOMNIO | es |
dc.subject | HIPNOTICOS Y SEDANTES | es |
dc.title | Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.4137/JCNSD.S1611 | - |
uca.path | Facultad de Ciencias Médicas|Departamento de Docencia e Investigación | es |
uca.disciplina | MEDICINA | es |
uca.filename | /home/data-uca-generic/folder_generic/IIBiomedicas/pharmacotherapy-of-insomnia-with-ramelteon/metadata.xml | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Pandi Perumal, Seithikurippu R. Somnogen Inc; Canadá | es |
uca.affiliation | Fil: Spence, David Warren. Investigador Independiente; Canadá | es |
uca.affiliation | Fil: Verster, Joris C. Universidad de Utrecht. Instituto de Ciencias Farmacéuticas de Utrecht. División de Farmacología; Holanda | es |
uca.affiliation | Fil: Srinivasan, Venkataramanujan. Sri Sathya Sai Medical Educational and Research Foundation; India | es |
uca.affiliation | Fil: Brown, Gregory M. Universidad de Toronto. Facultad de Medicina. Departamento de Psiquiatría; Canadá | es |
uca.affiliation | Fil: Brown, Gregory M. Centre for Addiction and Mental Health; Canadá | es |
uca.affiliation | Fil: Cardinali, Daniel Pedro. Universidad Católica Argentina. Facultad de Ciencias Médicas. Departamento de Docencia e Investigación; Argentina | es |
uca.affiliation | Fil: Cardinali, Daniel Pedro. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Fisiología; Argentina | es |
uca.affiliation | Fil: Hardeland, Rüdiger. Universidad de Goettingen. Insituto de Zoología y Antropología; Alemania | es |
uca.version | publishedVersion | es |
item.languageiso639-1 | en | - |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.orcid | 0000-0002-0813-9088 | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
pharmacotherapy-of-insomnia-with-ramelteon.pdf | 459,56 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
154
comprobado en 30-abr-2024
Descarga(s)
176
comprobado en 30-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons